US 11352350
IRAK degraders and uses thereof
granted A61KA61K45/06A61P
Quick answer
US patent 11352350 (IRAK degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K45/06, A61P, A61P25/00, A61P29/00